Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M.
Frohman EM, et al. Among authors: stuve o.
Arch Neurol. 2005 Oct;62(10):1519-30. doi: 10.1001/archneur.62.10.1519.
Arch Neurol. 2005.
PMID: 16216934
Review.